Featured Issue Free Article
Learning After You Know It All - Enhancing Compliance Learning and Maximizing Retention
Click here to view this article for free.
The full text of the entire issue is now available to our subscribers. If you are a subscriber please log in now. You may also buy this issue by clicking on the button below.
For the June Life Science Compliance Update, we have an exciting issue focusing on pricing, transparency and enforcement. First, we finish Chris Coburn’s three-part series about understanding publicly funded health programs together with Nico Fiorentino’s article describing the recent spate of state pricing legislation. On the transparency front, we feature an article on how to use Open Payments data to detect potential “sham” speaker programs by Dr. Mark Labovitz and Jeffrey DiFrancesco of Attest Open-PaymentsTM. Finally, on enforcement, we have articles by Kurt Stitcher discussing DOJ’s new FCPA “pilot program” and Robert Wilkey’s piece on the OIG’s new permissive exclusion criteria.
Through the Worm Hole (Part 3) – Setting a Standard for GP Compliance
Chris Cobourn, Managing Director, Huron Life Sciences
Pricing Bills Are Popping Up Everywhere
Nicodemo (Nico) Fiorentino, Esq., Senior Advisor, Research & Compliance, for G&M Health LLC, and Editorial Board Member, Life Science Compliance Update and Christina Bello, Esq., Regulatory Compliance Advisor, for G&M Health LLC
Detecting the “Sham” in Speaker Programs
Mark Labovitz, Ph.D., MBA and Jeffrey DiFrancesco, M.Sci., M.Eng., Principals, Attest Open-PaymentsTM
The Dreaded Performance Appraisal – How the FDA Is Doing with Medical Devices and the Medical Device Industry
Calisha D. Myers, Esq., Staff Writer for Life Science Compliance Update
Is the Carrot Bigger Than the Stick? – The DOJ’s FCPA “Pilot Program”
Kurt Stitcher, Senior Compliance Consultant
Thunderstruck – New OIG Guidance on Permissive Exclusion & Integrity Obligations
Robert N. Wilkey, Esq., Staff Writer for Life Science Compliance Update